Table 7 |
|||
|
Factors influencing the type of drugs provided for patients |
|||
|
Non-hospitals n (%) N = 191 |
Hospitals n (%) N = 34 |
Chi-square (p-value) |
|
|
|
|||
|
Necessity to make profit |
18 (9.4) |
3 (8.8) |
.01 (.60) |
|
Request by patients |
76 (39.8) |
5 (2.6) |
6.7 (.006) |
|
Idea of what the consumer prefers |
17 (8.9) |
5 (2.6) |
1.5 (.19) |
|
Patients apparent SES |
37 (19.4) |
10 (29.4) |
2.4 (.096) |
|
Providers' level of training |
31 (16.2) |
5 (2.6) |
.004 (.594) |
|
Need to be competitive |
5 (2.6) |
0 (0) |
.85 (.46) |
|
Drugs available |
35 (18.3) |
2 (5.9) |
2.8 (.07) |
|
Existing treatment policy/guidelines |
26 (13.6) |
1 (2.9) |
2.7 (.07) |
|
Information from regulatory bodies |
10 (5.2) |
0 (0) |
1.7 (.21) |
|
Pressures from wholesalers to repay |
89 (46.6) |
22 (64.7) |
.17 (.85) |
|
Promotion by manufacturers |
3 (1.6) |
0 (0) |
.50 (.63) |
|
Others |
14 (7.3) |
12 (35.3) |
5.6 (.014) |
|
|
|||
|
Onwujekwe et al. Malaria Journal 2009 8:246 doi:10.1186/1475-2875-8-246 |
|||
